Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | THRB | P10828 | 1/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19538272 | 0.85 | ALDH1A1 (0.33) | ALDH1A1LMNATHRBALOX15MAPK1 | |
| SCHEMBL22053017 | 0.77 | ALDH1A1 (0.41) | ALDH1A1LMNATHRBALOX15MAPK1 | |
| SCHEMBL18789463 | 0.66 | ALDH1A1 (0.36) | ALDH1A1LMNATHRBALOX15MAPK1 | |
| SCHEMBL25820020 | 0.66 | ALDH1A1 (0.37) | ALDH1A1LMNATHRBALOX15MAPK1 | |
| SCHEMBL15095714 | 0.65 | ALDH1A1 (0.35) | ALDH1A1LMNATHRBALOX15MAPK1 | |
| SCHEMBL26022084 | 0.64 | ALDH1A1 (0.38) | ALDH1A1LMNATHRBALOX15MAPK1 | |
| SCHEMBL25819931 | 0.64 | ALDH1A1 (0.38) | ALDH1A1LMNATHRBALOX15MAPK1 | |
| SCHEMBL15095733 | 0.61 | ALDH1A1 (0.36) | ALDH1A1LMNATHRBALOX15MAPK1 | |
| SCHEMBL26022129 | 0.61 | ALDH1A1 (0.36) | ALDH1A1LMNATHRBALOX15MAPK1 | |
| SCHEMBL15095712 | 0.59 | ALDH1A1 (0.34) | ALDH1A1LMNATHRBALOX15MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2947078-B1 | Novel mixtures with (4aR, 5R, 7aS, 9R) -octahydro-2,2,5,8,8,9a-hexamethyl-4h-4a, 9-methanoazuleno (5,6-d) -1,3-dioxol) (ambrocenide ®) | SYMRISE AG (DE) | 2018-03-21 | — | — | EP | disclosed |